Skip to main navigation Skip to search Skip to main content

Drug delivery advances in mitigating inflammation via matrix metalloproteinases in respiratory diseases

  • Meenu Mehta
  • , Keshav Raj Paudel
  • , Nisha Panth
  • , Dikaia Xenaki
  • , Ronan MacLoughlin
  • , Brian G. Oliver
  • , Raimar Lobenberg
  • , Philip M. Hansbro
  • , Dinesh Kumar Chellappan
  • , Kamal Dua
  • University of Technology Sydney
  • Centenary Institute
  • Centre for Inflammation
  • School of Life Sciences
  • The University of Sydney
  • IDA Business Park
  • Royal College of Surgeons in Ireland
  • Trinity College Dublin
  • University of Alberta
  • International Medical University
  • Discipline of Pharmacy
  • Faculty of Pharmacy and Pharmaceutical Sciences
  • Priority Research Centre for Healthy Lungs
  • University of Newcastle
  • Shoolini University of Biotechnology and Management Sciences

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)437-439
Number of pages3
JournalNanomedicine
Volume16
Issue number6
DOIs
Publication statusPublished - Mar 2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • inflammation
  • matrix metalloproteinase
  • nanoparticles
  • novel drug delivery
  • respiratory diseases

Cite this